JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Botling, J.
Right arrow Articles by Perlmann, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Botling, J.
Right arrow Articles by Perlmann, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 272, Number 14, Issue of April 4, 1997 pp. 9443-9449
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Retinoic Acid Receptor/Retinoid X Receptor Heterodimers Can Be Activated through Both Subunits Providing a Basis for Synergistic Transactivation and Cellular Differentiation

(Received for publication, November 15, 1996, and in revised form, December 17, 1996)

Johan Botling Dagger , Diogo S. Castro § , Fredrik Öberg Dagger , Kenneth Nilsson Dagger and Thomas Perlmann §

From the Dagger  Laboratory of Tumor Biology, Department of Pathology, Uppsala University, S-751 85 Uppsala, Sweden and the § Ludwig Institute for Cancer Research, Box 240, S-171 77 Stockholm, Sweden

The receptor for 9-cis-retinoic acid, retinoid X receptor (RXR), forms heterodimers with several nuclear receptors, including the receptor for all-trans-retinoic acid, RAR. Previous studies have shown that retinoic acid receptor can be activated in RAR/RXR heterodimers, whereas RXR is believed to be a silent co-factor. In this report we show that efficient growth arrest and differentiation of the human monocytic cell line U-937 require activation of both RAR and RXR. Also, we demonstrate that the allosteric inhibition of RXR is not obligatory and that RXR can be activated in the RAR/RXR heterodimer in the presence of RAR ligands. Remarkably, RXR inhibition by RAR can also be relieved by an RAR antagonist. Moreover, the dose response of RXR agonists differ between RXR homodimers and RAR/RXR heterodimers, indicating that these complexes are pharmacologically distinct. Finally, the AF2 activation domain of both subunits contribute to activation even if only one of the receptors is associated with ligand. Our data emphasize the importance of signaling through both subunits of a heterodimer in the physiological response to retinoids and show that the activity of RXR is dependent on both the identity and the ligand binding state of its partner.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
C. Andreasson and P. O. Ljungdahl
The N-Terminal Regulatory Domain of Stp1p Is Modular and, Fused to an Artificial Transcription Factor, Confers Full Ssy1p-Ptr3p-Ssy5p Sensor Control
Mol. Cell. Biol., September 1, 2004; 24(17): 7503 - 7513.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
J. Lengqvist, A. Mata de Urquiza, A.-C. Bergman, T. M. Willson, J. Sjovall, T. Perlmann, and W. J. Griffiths
Polyunsaturated Fatty Acids Including Docosahexaenoic and Arachidonic Acid Bind to the Retinoid X Receptor {alpha} Ligand-binding Domain
Mol. Cell. Proteomics, July 1, 2004; 3(7): 692 - 703.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
A. Wallen-Mackenzie, A. M. de Urquiza, S. Petersson, F. J. Rodriguez, S. Friling, J. Wagner, P. Ordentlich, J. Lengqvist, R. A. Heyman, E. Arenas, et al.
Nurr1-RXR heterodimers mediate RXR ligand-induced signaling in neuronal cells
Genes & Dev., December 15, 2003; 17(24): 3036 - 3047.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
N. Matt, N. B. Ghyselinck, O. Wendling, P. Chambon, and M. Mark
Retinoic acid-induced developmental defects are mediated by RAR{beta}/RXR heterodimers in the pharyngeal endoderm
Development, May 15, 2003; 130(10): 2083 - 2093.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Aarnisalo, C.-H. Kim, J. W. Lee, and T. Perlmann
Defining Requirements for Heterodimerization between the Retinoid X Receptor and the Orphan Nuclear Receptor Nurr1
J. Biol. Chem., September 13, 2002; 277(38): 35118 - 35123.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. C. Guibal, C. Moog-Lutz, P. Smolewski, Y. Di Gioia, Z. Darzynkiewicz, P. G. Lutz, and Y. E. Cayre
ASB-2 Inhibits Growth and Promotes Commitment in Myeloid Leukemia Cells
J. Biol. Chem., January 4, 2002; 277(1): 218 - 224.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
D. S. Castro, E. Hermanson, B. Joseph, A. Wallen, P. Aarnisalo, A. Heller, and T. Perlmann
Induction of Cell Cycle Arrest and Morphological Differentiation by Nurr1 and Retinoids in Dopamine MN9D Cells
J. Biol. Chem., November 9, 2001; 276(46): 43277 - 43284.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. M. Cesario, K. Klausing, H. Razzaghi, D. Crombie, D. Rungta, R. A. Heyman, and D. S. Lala
The Rexinoid LG100754 Is a Novel RXR:PPAR{gamma} Agonist and Decreases Glucose Levels in Vivo
Mol. Endocrinol., August 1, 2001; 15(8): 1360 - 1369.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
A. M. d. Urquiza, S. Liu, M. Sjöberg, R. H. Zetterström, W. Griffiths, J. Sjövall, and T. Perlmann
Docosahexaenoic Acid, a Ligand for the Retinoid X Receptor in Mouse Brain
Science, December 15, 2000; 290(5499): 2140 - 2144.
[Abstract] [Full Text]


Home page
HypertensionHome page
K. Takeda, T. Ichiki, Y. Funakoshi, K. Ito, and A. Takeshita
Downregulation of Angiotensin II Type 1 Receptor by All-trans Retinoic Acid in Vascular Smooth Muscle Cells
Hypertension, January 1, 2000; 35(1): 297 - 302.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. S. Castro, M. Arvidsson, M. B. Bolin, and T. Perlmann
Activity of the Nurr1 Carboxyl-terminal Domain Depends on Cell Type and Integrity of the Activation Function 2
J. Biol. Chem., December 24, 1999; 274(52): 37483 - 37490.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C.-H. Lee and L.-N. Wei
Characterization of Receptor-interacting Protein 140 in Retinoid Receptor Activities
J. Biol. Chem., October 29, 1999; 274(44): 31320 - 31326.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. J. Dilworth, C. Fromental-Ramain, E. Remboutsika, A. Benecke, and P. Chambon
Ligand-dependent activation of transcription in vitro by retinoic acid receptor alpha /retinoid X receptor alpha  heterodimers that mimics transactivation by retinoids in vivo
PNAS, March 2, 1999; 96(5): 1995 - 2000.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
W. W. M. Pijnappel, G. E. Folkers, W. J. de Jonge, P. J. E. Verdegem, S. W. de Laat, J. Lugtenburg, H. F. J. Hendriks, P. T. van der Saag, and A. J. Durston
Metabolism to a response pathway selective retinoid ligand during axial pattern formation
PNAS, December 22, 1998; 95(26): 15424 - 15429.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Papadimou, S. Georgiou, D. Tsambaos, and D. Drainas
Inhibition of Ribonuclease P Activity by Retinoids
J. Biol. Chem., September 18, 1998; 273(38): 24375 - 24378.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
B Mascrez, M Mark, A Dierich, N. Ghyselinck, P Kastner, and P Chambon
The RXRalpha ligand-dependent activation function 2 (AF-2) is important for mouse development
Development, January 12, 1998; 125(23): 4691 - 4707.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. M. Zavacki, J. M. Lehmann, W. Seol, T. M. Willson, S. A. Kliewer, and D. D. Moore
Activation of the orphan receptor RIP14 by retinoids
PNAS, July 22, 1997; 94(15): 7909 - 7914.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Moog-Lutz, E. J. Peterson, P. G. Lutz, S. Eliason, F. Cave-Riant, A. Singer, Y. Di Gioia, S. Dmowski, J. Kamens, Y. E. Cayre, et al.
PRAM-1 Is a Novel Adaptor Protein Regulated by Retinoic Acid (RA) and Promyelocytic Leukemia (PML)-RA Receptor alpha in Acute Promyelocytic Leukemia Cells
J. Biol. Chem., June 15, 2001; 276(25): 22375 - 22381.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.